AGREEMENT AND PLAN OF MERGER AND ACQUISITION AGREEMENT AMONG PIVOT PHARMACEUTUCALS, INC. AND PIVOT PHARMA U.S. INC. AND INDUS PHARMACEUTICALS, INC., AND SINDU RESEARCH LABORATORIES PVT. LTD.Merger Agreement • November 23rd, 2015 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
This Merger Agreement (this ''Agreement'') is entered into as of November 4, 2015, by and among Pivot Pharmaceuticals, Inc. a British Columbia Corporation with its principal place of business located at 1275 West 6th Avenue, Vancouver, B.C., Canada, V6H 1A6 ("Buyer"), Pivot Pharma U.S. Inc., a Delaware corporation and a wholly owned Subsidiary of Buyer ("Merger Subsidiary"), IndUS Pharmaceuticals, Inc., a Delaware corporation ("Seller"), Sindu Research Laboratories Pvt Ltd., a corporation formed under the laws of India ("Sindu") and the Sindu Stockholders (as defined below). Buyer, Merger Subsidiary, Seller and Sindu are referred to collectively herein as the "Parties".
